Sabin Laboratory

What Sabin Laboratory does

Grupo Sabin is a privately held Brazilian diagnostic medicine company founded in 1989 in Brasília by biochemists Janete Vaz and Sandra Soares Costa. It operates one of the largest clinical laboratory and diagnostic imaging networks in Brazil, with 296 service units across the Federal District and 12 Brazilian states, employing 5,500+ collaborators and serving more than 5 million clients annually. Its service portfolio spans over 3,500 types of examinations, organized across four primary pillars: clinical laboratory testing (Exames Laboratoriais), diagnostic imaging (Exames de Imagem), vaccination (Vacinas), and a dedicated genomic medicine division (Sabin Genômica) offering NGS-based hereditary cancer panels, whole exome sequencing, and the proprietary Teste Genético da Bochechinha newborn screening test (covering 390+ genes and congenital CMV). Adjacent services include the Sabin Prime executive check-up program, VEM Sabin mobile home care, Unidade Digital (fully digital lab service), and an outpatient medication infusion service.

The underlying technology stack combines standard clinical chemistry and immunoassay analyzers with molecular biology infrastructure (PCR, NGS, bioinformatics pipelines for variant calling such as MPOX clade 1b detection) and digital health platforms including a mobile app, virtual store (loja.sabin.com.br), WhatsApp-based scheduling, and a physician portal. The company holds an unusually dense certification stack for a regional lab operator: CAP (first lab accredited in the Federal District), PALC, PADI, DICQ, ISO 9001/14001/31000, LEED Gold for its headquarters, and CBR's Selo de Excelência Socioambiental (a first in global diagnostic imaging). It is also LGPD-compliant with an appointed DPO.

Revenue mechanics are hybrid: recurring reimbursement from health insurance partners (Amil, Cassi, Camed, SulAmérica, among others), direct-pay B2C transactions via the virtual store and physical units, corporate account contracts (Atendimento a Empresas), and home care service fees. The GTM motion is omnichannel — physical units, digital self-serve, mobile, and field sales — with a clear enterprise sales function for corporate accounts. Customer mix is well-distributed across individual consumers, health insurance members, mothers/infants (genetic screening), and corporate B2B. No external equity funding rounds have been disclosed, indicating the business is funded through operating cash flow.

Name

Sabin Laboratory

Legal name

Grupo Sabin

Website

https://sabin.com.br

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Grupo Sabin is a privately held Brazilian diagnostic medicine company operating 296 clinical laboratory and imaging units across 13 states, serving 5M+ clients annually through clinical testing, imaging, vaccination, genomic services, and home care.

Ownership category

akta.pro rank

Product category

Medical Diagnostics Services

NAICS

Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK)

akta.pro secondary industries

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

Keywords

• Clinical laboratory diagnostics
• Diagnostic imaging services
• Genomic testing services
• Vaccination services
• Preventive health checkups

Headquarters

HQ city

Brasília

HQ country

Brazil

HQ region

Latin America

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Analysis Services: Laboratory tests including blood work, genetic tests, and specialized diagnostics. Revenue generated through health insurance reimbursements and direct patient payments.
2. Diagnostic Imaging: Medical imaging services including X-ray, MRI, CT scans, ultrasound, and mammography. Revenue through insurance and private pay.
3. Vaccination Services: Vaccine administration services including routine immunizations, travel vaccines, and specialty vaccines. Revenue through health insurance and out-of-pocket payments.
4. Executive Check-up (Sabin Prime): Comprehensive health assessment packages for corporate and individual clients.
5. Home Care Service (VEM Sabin): Mobile healthcare service bringing laboratory tests and vaccinations to homes, offices, or maternity wards.
6. Corporate Accounts: Business health services including workplace testing and corporate wellness programs.

Pricing tiers

Go-to-market motion2 records

Distribution channels7 records

Marketing channels9 records

Core offering

Sabin Diagnóstico e Saúde (Grupo Sabin) operates a national medical diagnostics platform in Brazil, delivering clinical laboratory testing, diagnostic imaging (MRI, CT, X-ray, ultrasound, mammography, densitometry), vaccination, genomic testing (NGS, exome, hereditary cancer, newborn genetic screen), executive health check-ups (Sabin Prime), outpatient medication infusion, and home-care phlebotomy (VEM Sabin). Services are accessed through ~296 physical units, a digital unit, a virtual store, a mobile app, a physician portal and home-care visits, with a portfolio of more than 3,500 examination types serving 5+ million clients annually.

Product overview

Sabin Diagnóstico e Saúde operates as a comprehensive diagnostic medicine platform offering a unified portfolio of laboratory testing, diagnostic imaging, vaccination, genomic testing, and executive health services. The core offering comprises laboratory exams and imaging services available across 296 physical units nationwide, supplemented by the Unidade Digital (fully digital laboratory unit), #VemSabin (mobile home service), and Sabin Genômica (genetic testing division). The ecosystem includes specialty services such as medication infusion therapy and executive check-up programs (Sabin Prime). The company serves over 5 million clients through 296 units in 14 Brazilian states plus the Federal District, with a portfolio of over 3,500 examination types.

Differentiator

Problem solved

Functional benefit

Brands

• Instituto Sabin: Social institute (Oscip) created in 2005 that promotes well-being, prosperity, and quality of life in communities where Grupo Sabin operates through social innovation programs.
• Sabin Genômica
• Sabin Prime
• VEM Sabin
• Unidade Digital

Products and services

• Exames Laboratoriais (Laboratory Testing) Clinical laboratory testing services including blood tests, clinical chemistry, immunological assays and other diagnostic examinations. Available across the physical unit network, the Digital Unit, the VEM Sabin home-care service and purchased individually through the virtual store.
• Exames de Imagem (Diagnostic Imaging) Diagnostic imaging services including X-ray, ultrasound, MRI, CT scan, mammography and densitometry, performed at select units such as the 24-hour Vega unit.
• Vacinas (Vaccination Services) Vaccination services covering routine immunizations, travel vaccines and specialty vaccines including HPV, Herpes Zoster (Shingrix), Influenza and RSV (Abrysvo), delivered across units and via home care.
• Check-up Executivo (Sabin Prime) Executive health check-up packages integrating multiple diagnostic assessments with a results consultation, offered to individual and corporate clients.
• Sabin Genômica (Genomic Testing Services) Genomic medicine services including genetic testing, DNA analysis, Next Generation Sequencing (NGS), whole exome sequencing, hereditary cancer panels and the Bochechinha newborn genetic screening, marketed under the Sabin Genômica sub-brand.
• Unidade Digital (Digital Laboratory Unit) A 100% digital laboratory service where customers purchase exams online, complete pre-registration and check in via QR code, attend only for sample collection, and receive digital results.
• #VemSabin (Atendimento Domiciliar / Home Care) Mobile phlebotomy and vaccination service that brings laboratory tests and vaccines to the customer's home, office or maternity ward, booked online or via WhatsApp.
• Infusão de Medicamentos (Medication Infusion Service) Outpatient infusion service treating autoimmune, inflammatory, intestinal and bone diseases, iron deficiency and infections requiring IV antibiotics, delivered at a dedicated Brasília unit.
• Teste Genético da Bochechinha (Newborn Genetic Screening) Newborn genetic screening that analyzes more than 390 genes for treatable diseases and adds congenital CMV and Turner syndrome screening in a single collection.
• Painel de Câncer Hereditário Expandido (Expanded Hereditary Cancer Panel) Expanded hereditary cancer genetic panel that evaluates predisposition to multiple cancer types, purchased through the virtual store and analyzed under the Sabin Genômica brand.
• Sequenciamento Completo do Exoma (Whole Exome Sequencing) Whole exome sequencing test that analyzes the protein-coding regions of genes to support comprehensive genetic diagnosis.
• MPOX PCR (Clade 1b Detection) Molecular PCR test that detects Mpox virus including the new clade 1b variant, analyzed by Sabin's Molecular Biology sector using bioinformatics.
• Mini Painel Respiratório (Respiratory Panel) RT-PCR respiratory panel that simultaneously detects SARS-CoV-2, Influenza A, Influenza B and Respiratory Syncytial Virus from a single patient sample.
• Vacina VSR (Abrysvo) RSV vaccine covering subtypes A and B, indicated for pregnant women between 24 and 36 weeks and for adults aged 60 and over, available via the virtual store and at units.
• Teste de Paternidade (DNA Paternity Test) DNA paternity test that supports trio, duo and deceased-father investigation scenarios, using genetic analysis from Sabin's laboratory.
• Loja Virtual (Online Store for Exams, Vaccines and Packages) Sabin's e-commerce storefront (loja.sabin.com.br) enabling individual customers and businesses to purchase laboratory tests, vaccines and health packages online with digital voucher delivery.
• Agenda de Exames 24h (24-hour Scheduling at Unidade Vega) 24-hour appointment and execution service for laboratory exams (hemogram, cholesterol, creatinine) and imaging (MRI, CT) at the Vega unit in Brasília's Asa Norte.

Quantifiable outcome

• Serving 5+ million clients annually with 5,500+ employees across 296 units
• +2 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature5 records

Partnerships

Three partnerships are on record, tiered core.

• Support Laboratories (Laboratórios de Apoio)coreTechnology or IntegrationNetwork of support laboratories for tests not yet internalized in Sabin's methodology. Partners follow same LGPD compliance criteria and hold quality certifications matching Grupo Sabin standards. Data sharing backed by health protection and contract execution legal bases.
• Health Insurance OperatorscoreChannel Partner/ Reseller/ DistributorExtensive network of health insurance operators accepting coverage at Sabin units. Includes Amil, Cassi, Camed, Casembrapa, Codevasf, Nova Saúde, Prevent Sênior, Serpro, Sul América, and others across all regions of Brazil.
• Instituto SabincoreOthersSocial investment arm of Grupo Sabin. Created in 2005 as an OScip (Civil Society Organization of Public Interest) managing R$ 4.5 million in social investment in 2024, with 67 partnerships and programs benefiting 1 million people.

Scale indicators11 records

Recent moves10 records

Expansion highlights6 records

Broad incumbents

• SYNLAB Group: Europe's largest clinical diagnostics provider with extensive routine and specialty testing networks. Useful comparator for Sabin's future ambitions in genomics, home collection, and international quality certifications.
• Quest Diagnostics: One of the largest U.S. clinical laboratory operators offering routine, specialty, and advanced diagnostics. Comparable in portfolio breadth, health-plan reimbursement model, and operational scale benchmarking for Sabin's eventual network economics.
• Eurofins Scientific: Global leader in bioanalytical testing across clinical, pharmaceutical, and food diagnostics. Comparable as a broad incumbent operating high-volume diagnostic testing infrastructure and clinical genomics offerings.
• Laboratory Corporation of America (Labcorp): Global leader in clinical diagnostics with routine and esoteric testing plus early development services. Comparable to Sabin in operating a high-volume clinical lab business serving physicians, employers, and patients.

Direct peers

• Hermes Pardini (now part of Dasa): Pre-acquisition by Dasa, Hermes Pardini operated as a large Minas Gerais-based diagnostics chain. Highly comparable in geographic focus, exam breadth, and health-insurance-driven revenue model — a useful sizing benchmark for Sabin's Center-West build-out.
• Laboratório Richet: Rio de Janeiro and regional Brazilian diagnostics chain offering clinical analysis, specialty testing, and home collection. Comparable to Sabin in serving both individual and corporate segments.
• Grupo Fleury: Largest Brazilian diagnostic medicine chain, offering clinical lab, imaging, and outpatient services across the country. Fleury is the most direct comparison for Sabin's portfolio, scale ambition, and customer mix (B2C, health plans, corporate accounts).
• Dasa (Diagnósticos da América): Brazil's largest diagnostics platform following consolidation of multiple regional brands (including Hermes Pardini and APD). Direct competitor across lab, imaging, and genomics with similar insurance-network economics.
• Grupo Pasteur Diagnóstica: Mid-sized São Paulo-area diagnostics group with clinical laboratory and imaging services. Comparable to Sabin in middle-market positioning, health-plan reliance, and growth-via-unit-expansion strategy.

Emerging players

• Hospital Israelita Albert Einstein: Brazilian hospital system that expanded into outpatient diagnostics and laboratory services. Comparable to Sabin in serving premium São Paulo/Brazil markets with broad diagnostics and genomics capabilities, and an emerging competitor in the integrated diagnostics category.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/sabinbr_
• YouTubeyoutube.com/@sabinbr_
• Facebookfacebook.com/sabindiagnosticoesaude
• LinkedInlinkedin.com/company/grupo-sabin
• Instagraminstagram.com/sabinbr_
• TikToktiktok.com/@sabinbr_

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sabin Laboratory